MORF(MORF)
MORF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2M | $2M | $127M |
| Low | $2M | $2M | $127M |
| High | $2M | $2M | $127M |
| EBITDA Avg | $-2M | $-2M | $-125M |
| Low | $-2M | $-2M | $-125M |
| High | $-2M | $-2M | $-125M |
| EBIT Avg | $-2M | $-2M | $-125M |
| Low | $-2M | $-2M | $-125M |
| High | $-2M | $-2M | $-125M |
| Net Income Avg | $-168M | $-174M | $-155M |
| Low | $-203M | $-174M | $-155M |
| High | $-133M | $-174M | $-155M |
| EPS Avg | $-3.76 | $-4.11 | $-3.66 |
| Low | $-4.80 | $-4.11 | $-3.66 |
| High | $-3.14 | $-4.11 | $-3.66 |
| Analysts (Rev / EPS) | 7 / 6 | 3 / 2 | 4 / 3 |